Skip to content

US · MIR · INDUSTRIAL - MACHINERY

Mirion Technologies, Inc. (MIR) intrinsic value and stock valuation

$16.07as of 2026-11-21 · Mkt cap 3.75B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Mirion Technologies, Inc. DCF and intrinsic value

InvestorsCraft values MIR with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from MIR’s statements →

Mirion Technologies, Inc. Graham Number

Graham Number: $4.85d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Industrial - Machinery Atlanta, GA 30318 mirion.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$925.4M
20182025
Net income
$28.8M
20182025
Free cash flow
$106.9M+40.4% 5y CAGRd
20182025
Total equity
$1.92B
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$925.4M$860.8M$800.9M$717.8M$668.3M
Operating income$51.5M$24.8M-$-21.9M-$-297.8M-$-68.7M
Net income$28.8M-$-36.1M-$-96.9M-$-276.9M-$-222.5M
EPSd$110.3K-$-176.11K-$-493.46K-$-1.53M-$-1.07M
Operating cash flow$143.3M$99.1M$95.2M$39.4M$900K
Capital expenditure-$-36.4M-$-48.8M-$-37.1M-$-34.2M-$-17.6M
Free cash flow$106.9M$50.3M$58.1M$5.2M-$-16.7M
Total assets$3.59B$2.64B$2.72B$2.74B$3.12B
Total debt$1.23B$719.9M$721M$849.6M$860.6M
Net debt$821.4M$544.7M$592.2M$776.1M$776.6M
Total equity$1.92B$1.56B$1.55B$1.47B$1.78B
Cash and short-term investments$419.2M$181.1M$134.1M$77.8M$88.9M
Income statement
20252024202320222021
Revenue$925.4M$860.8M$800.9M$717.8M$668.3M
Cost of revenue$486.8M$459M$444.4M$400.6M$384.1M
Gross profit$438.6M$401.8M$356.5M$317.2M$284.2M
Research and development expenses$38.9M$35M$31.7M$30.3M$36.2M
Selling, general and administrative expenses$348.2M$338.2M$338.6M$357.1M$267.6M
Other expenses$0.00$3.8M$8.1M$227.6M$49.1M
Operating expenses$387.1M$377M$378.4M$615M$352.9M
Cost and expenses$873.9M$836M$822.8M$1.02B$737M
Interest income$12.1M$6.6M$4.8M$600K$145.8M
Interest expense$42.2M$57.9M$61.9M$42.5M$59M
Depreciation and amortization$138M$150.4M$162.8M$174.5M$112.2M
Ebitda$212.9M$179M$149M$104.3M$92.6M
Operating income$51.5M$24.8M-$-21.9M-$-297.8M-$-68.7M
Total other income/expenses, net-$-18.8M-$-58.7M-$-83.4M-$-8.8M-$-159.8M
Income before tax$32.7M-$-33.9M-$-105.3M-$-306.6M-$-228.5M
Income tax expense$2.9M$2.7M-$-6.6M-$-18.2M-$-5.1M
Net income$28.8M-$-36.1M-$-96.9M-$-276.9M-$-222.5M
Weighted average shares outstanding$230M$205M$196.4M$181.2M$208.1M
Weighted average diluted shares outstanding$261.2M$205M$196.4M$181.2M$208.1M
Balance sheet
20252024202320222021
Cash and short-term investments$419.2M$181.1M$134.1M$77.8M$88.9M
Net receivables$290M$253.3M$230.4M$225.6M$219.7M
Inventory$152.6M$133.2M$144.1M$143.3M$123.6M
Total current assets$893.7M$594.7M$538.6M$480.6M$453.4M
Property, plant and equipment, net$187M$176.6M$167.4M$164.9M$169.7M
Goodwill and intangible assets$2.48B$1.84B$1.99B$2.07B$2.47B
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$2.69B$2.04B$2.18B$2.23B$2.66B
Total assets$3.59B$2.64B$2.72B$2.74B$3.12B
Accounts payable$57.4M$56.5M$58.7M$67.7M$59.4M
Short-term debt$9.3M$7.6M$8.1M$13.8M$13.2M
Deferred revenue$131.8M$110.9M$103.4M$83M$81.8M
Total current liabilities$316.1M$263.5M$265.7M$244.3M$221M
Long-term debt$1.22B$712.3M$712.9M$835.9M$847.4M
Deferred revenue, non-current$0.00$3M$0.00$0.00$0.00
Total non-current liabilities$1.36B$813.5M$902.8M$1.03B$1.11B
Capital lease obligations$34.5M$33.5M$35.1M$42.9M$49.9M
Total liabilities$1.67B$1.08B$1.17B$1.27B$1.33B
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-512.7M-$-541.5M-$-505.4M-$-408.5M-$-131.6M
Accumulated other comprehensive income (loss)-$-52.6M-$-93M-$-65.3M-$-75.7M-$-20.7M
Total equity$1.92B$1.56B$1.55B$1.47B$1.78B
Total investments$6.9M$5.9M$5.3M$4.3M$4.9M
Total debt$1.23B$719.9M$721M$849.6M$860.6M
Net debt$821.4M$544.7M$592.2M$776.1M$776.6M
Cash flow statement
20252024202320222021
Net income$28.8M-$-36.6M-$-96.9M-$-288.4M-$-127.9M
Depreciation and amortization$138M$150.4M$162.5M$174.5M$62.9M
Stock-based compensation$15.2M$15.6M$21.9M$31.8M$0.00
Change in working capital-$-15.7M-$-26.8M-$-700K-$-38.4M-$-11M
Accounts receivable$6.2M-$-12M-$-5M-$-19.3M-$-24.3M
Inventory$4M$1.3M-$-500K-$-34.8M-$-5.1M
Accounts payable-$-10.8M-$-1.5M-$-9.9M$4.5M$10.3M
Net cash provided by operating activities$143.3M$99.1M$95.2M$39.4M$900K
Investments in property, plant and equipment-$-36.4M-$-48.8M-$-37.1M-$-34.2M-$-17.6M
Acquisitions, net-$-661.9M-$-1M-$-30.4M-$-6.6M-$-2.18B
Net cash used for investing activities-$-694.6M-$-43.7M-$-64.7M-$-39.5M-$-2.2B
Common stock issued$409.7M$0.00$150M$0.00$860.4M
Common stock repurchased-$-49.6M-$-2M-$-1M$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$775.9M-$-3.3M$22.6M-$-7M$1.54B
Net change in cash$239.6M$45.1M$55.5M-$-10.3M$84.2M
Cash at end of period$415.2M$175.6M$130.5M$75M$84.6M
Operating cash flow$143.3M$99.1M$95.2M$39.4M$900K
Capital expenditure-$-36.4M-$-48.8M-$-37.1M-$-34.2M-$-17.6M
Free cash flow$106.9M$50.3M$58.1M$5.2M-$-16.7M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Mirion Technologies, Inc.

        Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

        CEO
        Thomas D. Logan
        Employees
        3.28K
        Beta
        1.03

        Explore

        Frequently asked questions

        What is the intrinsic value of Mirion Technologies, Inc. (MIR)?

        Mirion Technologies, Inc. (MIR) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is MIR undervalued?

        MIR trades at a price of $16.07 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.